180 related articles for article (PubMed ID: 25912799)
1. Biochemical characterization and molecular dynamic simulation of β-sitosterol as a tubulin-binding anticancer agent.
Mahaddalkar T; Suri C; Naik PK; Lopus M
Eur J Pharmacol; 2015 Aug; 760():154-62. PubMed ID: 25912799
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of the anticancer potential and tubulin isotype-specific interactions of β-sitosterol.
Pradhan M; Suri C; Choudhary S; Naik PK; Lopus M
J Biomol Struct Dyn; 2018 Jan; 36(1):195-208. PubMed ID: 27960611
[TBL] [Abstract][Full Text] [Related]
3. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of aryl dihydrothiazol acyl shikonin ester derivatives as anticancer agents through microtubule stabilization.
Lin HY; Li ZK; Bai LF; Baloch SK; Wang F; Qiu HY; Wang X; Qi JL; Yang RW; Wang XM; Yang YH
Biochem Pharmacol; 2015 Jul; 96(2):93-106. PubMed ID: 25957661
[TBL] [Abstract][Full Text] [Related]
5. CXI-benzo-84 reversibly binds to tubulin at colchicine site and induces apoptosis in cancer cells.
Rai A; Gupta TK; Kini S; Kunwar A; Surolia A; Panda D
Biochem Pharmacol; 2013 Aug; 86(3):378-91. PubMed ID: 23747346
[TBL] [Abstract][Full Text] [Related]
6. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
[TBL] [Abstract][Full Text] [Related]
7. beta-Sitosterol induces G2/M arrest, endoreduplication, and apoptosis through the Bcl-2 and PI3K/Akt signaling pathways.
Moon DO; Kim MO; Choi YH; Kim GY
Cancer Lett; 2008 Jun; 264(2):181-91. PubMed ID: 18314257
[TBL] [Abstract][Full Text] [Related]
8. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
9. Structural Basis of Noscapine Activation for Tubulin Binding.
Oliva MA; Prota AE; Rodríguez-Salarichs J; Bennani YL; Jiménez-Barbero J; Bargsten K; Canales Á; Steinmetz MO; Díaz JF
J Med Chem; 2020 Aug; 63(15):8495-8501. PubMed ID: 32657585
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of benzoylacrylic acid shikonin ester derivatives as irreversible dual inhibitors of tubulin and EGFR.
Sun WX; Han HW; Yang MK; Wen ZL; Wang YS; Fu JY; Lu YT; Wang MY; Bao JX; Lu GH; Qi JL; Wang XM; Lin HY; Yang YH
Bioorg Med Chem; 2019 Dec; 27(23):115153. PubMed ID: 31648877
[TBL] [Abstract][Full Text] [Related]
11. Indirubin, a bis-indole alkaloid binds to tubulin and exhibits antimitotic activity against HeLa cells in synergism with vinblastine.
Mohan L; Raghav D; Ashraf SM; Sebastian J; Rathinasamy K
Biomed Pharmacother; 2018 Sep; 105():506-517. PubMed ID: 29883946
[TBL] [Abstract][Full Text] [Related]
12. Biological evaluation and molecular modelling study of podophyllotoxin derivatives as potent inhibitors of tubulin polymerization.
Ma Y; Fang S; Li H; Han C; Lu Y; Zhao Y; Liu Y; Zhao C
Chem Biol Drug Des; 2013 Jul; 82(1):12-21. PubMed ID: 23786349
[TBL] [Abstract][Full Text] [Related]
13. Indicine N-oxide binds to tubulin at a distinct site and inhibits the assembly of microtubules: a mechanism for its cytotoxic activity.
Appadurai P; Rathinasamy K
Toxicol Lett; 2014 Feb; 225(1):66-77. PubMed ID: 24300171
[TBL] [Abstract][Full Text] [Related]
14. A novel orally active microtubule destabilizing agent S-40 targets the colchicine-binding site and shows potent antitumor activity.
Du T; Lin S; Ji M; Xue N; Liu Y; Zhang Z; Zhang K; Zhang J; Zhang Y; Wang Q; Sheng L; Li Y; Lu D; Chen X; Xu H
Cancer Lett; 2020 Dec; 495():22-32. PubMed ID: 32931884
[TBL] [Abstract][Full Text] [Related]
15. A molecular docking study of anticancer drug paclitaxel and its analogues.
Sinha R; Vidyarthi AS; Shankaracharya
Indian J Biochem Biophys; 2011 Apr; 48(2):101-5. PubMed ID: 21682141
[TBL] [Abstract][Full Text] [Related]
16. Structures of potent anticancer compounds bound to tubulin.
McNamara DE; Senese S; Yeates TO; Torres JZ
Protein Sci; 2015 Jul; 24(7):1164-72. PubMed ID: 25970265
[TBL] [Abstract][Full Text] [Related]
17. Reversible binding of the anticancer drug KXO1 (tirbanibulin) to the colchicine-binding site of β-tubulin explains KXO1's low clinical toxicity.
Niu L; Yang J; Yan W; Yu Y; Zheng Y; Ye H; Chen Q; Chen L
J Biol Chem; 2019 Nov; 294(48):18099-18108. PubMed ID: 31628188
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel class of tubulin inhibitors with promising anticancer activities.
Xi J; Zhu X; Feng Y; Huang N; Luo G; Mao Y; Han X; Tian W; Wang G; Han X; Luo R; Huang Z; An J
Mol Cancer Res; 2013 Aug; 11(8):856-64. PubMed ID: 23666368
[TBL] [Abstract][Full Text] [Related]
19. 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells.
Jiang JD; Davis AS; Middleton K; Ling YH; Perez-Soler R; Holland JF; Bekesi JG
Cancer Res; 1998 Dec; 58(23):5389-95. PubMed ID: 9850070
[TBL] [Abstract][Full Text] [Related]
20. Electrostatic contributions to colchicine binding within tubulin isotypes.
Huzil JT; Barakat K; Tuszynski JA
Electromagn Biol Med; 2009; 28(4):355-64. PubMed ID: 20017626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
